This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Market For Stem Cell Research Products: Current And Future Opportunities

NEW YORK, March 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Market for Stem Cell Research Products: Current and Future Opportunities http://www.reportlinker.com/p01117629/The-Market-for-Stem-Cell-Research-Products-Current-and-Future-Opportunities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize the way many diseases are treated. Pharmaceutical and biotech companies are seeking to leverage portfolios beleaguered by high drug attrition rates and expiring patents, and the use of stem cells in the drug discovery phase, rapid developments in regenerative medicine and the emergence of novel cell- based therapies promise to offer exciting new revenue streams. Increasingly, industry and academic institutions are collaborating on stem cell research and product development.

But given that practical stem-cell based therapies can take years to develop and are often stalled by heavy regulation, suppliers are in need of gaining a clear understanding of the wide range of products that support the stem cell research that is currently underway in both academic and industrial labs.

The Market for Stem Cell Research Products: Current and Future Opportunities, BioInformatics LLC's latest report, was designed to help suppliers assess how today's stem cell products market is driven by ongoing stem cell research requirements and how to best address the needs of the current market, to include a market size estimate (by expenditure) for stem cell products and lines worldwide. We surveyed 371 scientists from around the world about their current—and planned—areas of research, usage of stem cell products and preferred suppliers. This report will help decision-makers determine areas poised for growth (i.e., media, sera, supplements and cell lines) in the stem cell research products market, identify key competitors (including expenditure share for each major supplier), and plan a long- term strategy to secure a leading position in this expanding market. Combined with data on scientists' stem cell research budgets and predicted changes in spending through 2015, suppliers can use this information to anticipate areas of growth and product saturation.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs